Product correctly added to cart.

discount label
DSP-2230
View 3D

Biosynth logo

DSP-2230

CAS: 1233231-30-5

Ref. 3D-IZB23130

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 25 Jun 2024

Product Information

Name:
DSP-2230
Description:

DSP-2230 is a study drug that is designed to block the sodium channel. It has been shown to be safe and well tolerated in humans, with no significant side effects. DSP-2230 showed potential to reduce symptoms of neuropathic pain in human subjects and was tested for its ability to block radiation-induced damage to DNA. In addition, it inhibits the activity of ultraviolet (UV) radiation on women's skin. The mechanism of action in this case is not known, but may involve inhibiting the production of reactive oxygen species and/or blocking UV-induced increases in DNA strand breaks.

6-Fluoro-3-indoxyl-beta-D-galactopyranoside
This product is used as an antituberculosis drug that belongs to the class of rifamycins. Rifapentine inhibits bacterial growth by binding to DNA dependent RNA polymerase which prevents transcription and replication. It also specifically binds markers expressed at high

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
419.4 g/mol
Formula:
C20H20F3N5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IZB23130 DSP-2230

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".